Strategic Partnerships NovaBiotics has recently formalized a collaboration with Liverpool School of Tropical Medicine and partnered with Lstmed, presenting a clear path for co-development opportunities and joint funding prospects in antimicrobial and inflammatory disease areas.

Clinical-Stage Focus With a pharma division housing advanced clinical-stage candidates addressing unmet life-limiting diseases, there are potential licensing, co-development, or research services opportunities for biotech, CROs, and health systems seeking innovative therapies.

Diversified Revenue A dual revenue model spanning consumer personal care products and clinical-stage therapeutics suggests cross-sell potential to healthcare retailers, distribution partners, and contract manufacturers seeking to diversify portfolios with biotech-backed brands.

Governance & Growth Strategic board appointments and ongoing funding milestones indicate an organization open to advisory services, strategic investments, and consulting partnerships to accelerate clinical programs and market entry strategies.

Geographic & Market Traction Recognition as a top Scottish biotech firm and active grant funding history position NovaBiotics for regional expansion, government-funded trials, and regional distribution deals in antimicrobial, respiratory, and personal care segments.